Product Images Maxalt
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Maxalt NDC 21695-956 by Rebel Distributors Corp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The text provides a graph showing the estimated probability of headache response over time after treatment with izairptan or placebo. The data is based on four outpatient trials and censored at 2 hours for patients not achieving headache response or taking additional treatment.*
The text contains a description of a Kaplan-Meier plot of the probability of obtaining headache response after treatment with MAXALT-MLT or placebo based on data from two placebo-controlled trials. The plot shows the average probabilities over time, and patients who did not achieve response within 2 hours or took additional treatment were censored at 2 hours.*
This text contains some errors and is not readable. Please provide a clear and accurate text for me to evaluate.*
Maxalt 10mg is a medication that comes in the form of tablets. Each tablet contains 10mg of Rizatriptan Benzoate, which is equivalent to 8mg of Rizatriptan. The package contains 18 tablets. The product is identified by the Product ID: RM095618. This medication is manufactured by MSD, Ltd. in Cramlington, Northumberland, NE23 3JU, UK.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.